Publications by authors named "S R Haussen"

Introduction: Considerable progress has been made in the treatment of patients with relapsing-remitting multiple sclerosis (MS) over the last decade. Exactly how these changes are reflected in daily practice, however, is still not very well known.

Aim: To hold interactive workshops so as to be able to evaluate the opinions of Latin-American neurologists about the therapeutic decisions taken with regard to MS.

View Article and Find Full Text PDF
Article Synopsis
  • The Brazilian Stroke Society formed a committee of specialists from various regions to create a guideline called "National Opinion," aimed at providing guidance on diagnosis and treatment for cerebrovascular diseases.
  • This article focuses on the use of neuroprotective agents in stroke, evaluating the evidence supporting potential neuroprotective medications.
  • It also highlights ongoing clinical trials related to these neuroprotective drugs and their effectiveness in stroke management.
View Article and Find Full Text PDF

The aim of this study was to assess the prevalence of Antimicrosomal Antibodies AMA, thyroid function and the occurrence of hypothyroidism symptoms in patients with Multiple Sclerosis (MS). Clinical examination was carried out in 21 MS patients; thyroid-stimulating hormone (TSH), thyroxine (T4), free T4 and AMA were measured. Mean age was 41.

View Article and Find Full Text PDF

The objective is to investigate the presence of dysphonic symptoms in multiple sclerosis (MS) patients and to compare quantitative acoustic parameters in multiple sclerosis patients and normal individuals. The method of study was an 8-month controlled cross-sectional that was carried out with 106 individuals (30 MS, 76 controls). Both groups included males and females from 20 to 55 years.

View Article and Find Full Text PDF

Multiple sclerosis is an inflammatory disease in which immunological mechanisms play an important role in causing demyelinating lesions in the central nervous system. A number of drugs acting in different stages of these mechanisms have been tested for its treatment. This paper analyses the most important clinical trials with glucocorticoids and immunomodulatory treatments, including human immunoglobulin, using the classes of evidences and types of recommendations as have been defined and widely accepted by the international scientific community.

View Article and Find Full Text PDF